|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Services revenue | ||||
| Grant revenue | ||||
| Total revenue | ||||
| Cost of revenue: | ||||
| Cost of services revenue (including depreciation) | ||||
| Cost of grant revenue | ||||
| Contract loss (adjustments) provisions | ||||
| Total cost of revenue | ||||
| Gross profit (loss) | ||||
| Operating expenses: | ||||
| Selling, general and administrative | ||||
| Research and development | ||||
| Impairment charges | ||||
| Impairment and other charges | ||||
| Total operating expenses | ||||
| Operating income (loss) | ||||
| Interest income | ||||
| SAFE instruments remeasurement | ||||
| Gain on warrant remeasurement | ||||
| Other income, net | ||||
| Net income (loss) before taxes | ||||
| Provision for income taxes | ||||
| Net income (loss) | ||||
| Unrealized losses on available-for-sale securities | ||||
| Cumulative translation adjustment | ||||
| Total comprehensive loss | ||||
| Earnings (loss) per share: | ||||
| Earnings (loss) per share – basic (in dollars per share) | ||||
| Earnings (loss) per share – diluted (in dollars per share) | ||||
| Weighted-average number of shares outstanding: | ||||
| Weighted-average number of shares outstanding – basic (in shares) | ||||
| Weighted-average number of shares outstanding – diluted (in shares) | ||||
Loading...
